check_circleStudy Completed
Pneumonia, Aspiration, Lung Abscess
Bayer Identifier:
10381
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
BAY12-8039, iv/oral Pulmonary Abscess/Aspiration Pneumonia
Trial purpose
The purpose of this trial is to determine the efficacy and safety of Moxifloxacin in comparison to Sulbactam/Ampicillin in the treatment of pulmonary abscesses and aspiration pneumonia.
Key Participants Requirements
Sex
BothAge
18 YearsTrial summary
Enrollment Goal
139Trial Dates
February 2001 - January 2005Phase
Phase 3Could I Receive a placebo
NoProducts
Avelox (Moxifloxacin hydrochloride, BAY12-8039)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Helios Klinikum Emil von Behring | Berlin, 14165, Germany |
Completed | Klinikum Lüdenscheid- Untern.verb. Märkische Kliniken GmbH | Lüdenscheid, 58515, Germany |
Completed | Kliniken Nord und Süd | Nürnberg, 90419, Germany |
Completed | Diakoniekrankenhaus | Rotenburg, 27356, Germany |
Completed | Universitätsklinikum Schleswig-Holstein | Lübeck, 23538, Germany |
Completed | Universitätsklinikum Otto-von Guericke - Magdeburg | Magdeburg, 39112, Germany |
Completed | Klinikum der Universität Regensburg | Regensburg, 93053, Germany |
Completed | Charité Campus Virchow-Klinikum (CVK) | Berlin, 13353, Germany |
Completed | Brüderkrankenhaus St. Josef | Paderborn, 33098, Germany |
Completed | St. Josef-Hospital | Oberhausen, 46045, Germany |
Completed | Johanniter-Krankenhaus in Fläming gGmbH | Treuenbrietzen, 14929, Germany |
Completed | Klinikum Mannheim gGmbH | Mannheim, 68167, Germany |
Completed | Städt. Krankenhaus Hildesheim GmbH | Hildesheim, 31134, Germany |
Completed | Klinikum der Johann Wolfgang Goethe Universität | Frankfurt, 60596, Germany |
Completed | Städtisches Klinikum "St. Georg" Leipzig | Leipzig, 04129, Germany |
Primary Outcome
- Adverse events occuring after first application of study medication up to the test of cure visit for non-serious adverse eventsdate_rangeTime Frame:Up to 30 days after end of treatment with study medication for serious adverse eventsenhanced_encryptionnoSafety Issue:
Secondary Outcome
- Clinical Responsedate_rangeTime Frame:Regulary doing i.v. treatmentenhanced_encryptionnoSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
RandomizedBlinding
Open LabelAssignment
Parallel AssignmentTrial Arms
2